-
1دورية أكاديمية
المؤلفون: Peter Mohr, Emilie Scherrer, Chalid Assaf, Marc Bender, Carola Berking, Sheenu Chandwani, Thomas Eigentler, Imke Grimmelmann, Ralf Gutzmer, Sebastian Haferkamp, Jessica C. Hassel, Axel Hauschild, Rudolf Herbst, Ruixuan Jiang, Katharina C. Kähler, Clemens Krepler, Alexander Kreuter, Ulrike Leiter, Carmen Loquai, Friedegund Meier, Claudia Pföhler, Anja Rudolph, Dirk Schadendorf, Maximo Schiavone, Gaston Schley, Patrick Terheyden, Selma Ugurel, Jens Ulrich, Jochen Utikal, Carsten Weishaupt, Julia Welzel, Michael Weichenthal
المصدر: Cancers, Vol 14, Iss 7, p 1804 (2022)
مصطلحات موضوعية: advanced melanoma, surrogate endpoint, real-world evidence, overall survival (OS), time to next treatment (rwTtNT), pembrolizumab, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Gaëlle Farge, Laurent Mortier, Stéphane Dalle, Olivier Dereure, Sheenu Chandwani, Caroline Dutriaux, Sophie Dalac, Laurie Levy-Bachelot, Laetitia Verdoni, Emilie Scherrer, Clara Allayous, Céleste Lebbé, Emilie Casarotto, B. Oriano
المساهمون: MSD France, Merck & Co. Inc, CHU Lille, Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), CHU Montpellier, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Hôpital Saint-André, CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hospices Civils de Lyon (HCL), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard [Lyon]-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Immunologie humaine, physiopathologie & immunothérapie (HIPI (UMR_S_976 / U976)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)
المصدر: Immunotherapy
Immunotherapy, 2021, 13 (11), pp.905-916. ⟨10.2217/imt-2021-0077⟩مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Skin Neoplasms, Databases, Factual, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, Kaplan-Meier Estimate, Pembrolizumab, Antibodies, Monoclonal, Humanized, computer.software_genre, Tumor response, survival, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, cohort study, medicine, Overall survival, Humans, Immunology and Allergy, Stage (cooking), Immune Checkpoint Inhibitors, Melanoma, Aged, Advanced melanoma, Aged, 80 and over, Database, business.industry, Immunotherapy, Middle Aged, medicine.disease, Treatment Outcome, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Female, immunotherapy, pembrolizumab, France, business, computer, Cohort study
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eeecf15ac2f76c4e915b9fc7920c053Test
https://doi.org/10.2217/imt-2021-0077Test -
3
المؤلفون: Charles Lance Cowey, Emilie Scherrer, April Beeks, Clemens Krepler, Marley Boyd, Kathleen M. Aguilar
المصدر: Cancer Medicine, Vol 9, Iss 21, Pp 7863-7878 (2020)
Cancer Medicineمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Skin Neoplasms, Time Factors, Programmed Cell Death 1 Receptor, Medical Oncology, immunology, 0302 clinical medicine, Risk Factors, Medicine, Community Health Services, Molecular Targeted Therapy, Immune Checkpoint Inhibitors, Melanoma, Original Research, Community based, Aged, 80 and over, Middle Aged, MAP Kinase Kinase Kinases, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Progression-Free Survival, 030220 oncology & carcinogenesis, Female, Drug Utilization, Adult, Proto-Oncogene Proteins B-raf, medicine.medical_specialty, First line, Risk Assessment, survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Humans, Radiology, Nuclear Medicine and imaging, Protein Kinase Inhibitors, Advanced melanoma, Aged, Retrospective Studies, Adult patients, business.industry, target therapy, Clinical Cancer Research, biomarkers, Retrospective cohort study, 030104 developmental biology, Propensity score matching, Mutation, Observational study, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96fc6bc46c16e1f918585ef9a89a846dTest
https://doaj.org/article/ee976dd75d584d12914c8df2bc5510e8Test -
4
المؤلفون: Steven M. Townson, James Larkin, Emilie Scherrer, Reina Rau, Irene Shui, Maria Lorenzi
المصدر: Future oncology (London, England). 17(20)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Metastatic melanoma, Clinical Decision-Making, Programmed Cell Death 1 Receptor, Risk Assessment, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, medicine, Overall survival, Biomarkers, Tumor, Humans, Immune Checkpoint Inhibitors, Melanoma, Advanced melanoma, business.industry, Patient Selection, Anti pd 1, General Medicine, medicine.disease, Progression-Free Survival, 030104 developmental biology, Systematic review, 030220 oncology & carcinogenesis, Biomarker (medicine), business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7c394dfb2529278b1dd27e417d8c10cTest
https://pubmed.ncbi.nlm.nih.gov/33783230Test -
5
-
6
المؤلفون: Emilie Scherrer, Eric Druyts, Hussein Tawbi, Irene Shui, Andrew Frederickson
المصدر: Journal for ImmunoTherapy of Cancer. 9:A339-A339
مصطلحات موضوعية: Pharmacology, Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Immunology, Anti pd 1, Immunotherapy, Internal medicine, Molecular Medicine, Immunology and Allergy, Medicine, business, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::c80f3173bbaed1027f6f5053ec9ed425Test
https://doi.org/10.1136/jitc-2021-sitc2021.315Test -
7
المؤلفون: Todd A. Lee, Frank Xiaoqing Liu, Alicia C. Shillington, Emilie Scherrer, Vaidehi Dave, Scott J. Diede, Richard W. Joseph, Qing Harshaw, Cynthia Macahilig
المصدر: Journal of medical economics. 23(2)
مصطلحات موضوعية: Oncology, Male, Skin Neoplasms, medicine.medical_treatment, Pembrolizumab, Comorbidity, Severity of Illness Index, 0302 clinical medicine, Antineoplastic Agents, Immunological, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Neoplasm Metastasis, Melanoma, Aged, 80 and over, 030503 health policy & services, Health Policy, Age Factors, Health Services, Middle Aged, Hospitalization, Nivolumab, 030220 oncology & carcinogenesis, Health Resources, Female, 0305 other medical science, Emergency Service, Hospital, medicine.drug, Adult, medicine.medical_specialty, Ipilimumab, Antibodies, Monoclonal, Humanized, Disease-Free Survival, 03 medical and health sciences, Sex Factors, Internal medicine, medicine, Humans, Advanced melanoma, Aged, Neoplasm Staging, Retrospective Studies, business.industry, Immunotherapy, Emergency department, medicine.disease, Regimen, Socioeconomic Factors, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea03f3e3d324c5e59f46dbc80ab03ca2Test
https://pubmed.ncbi.nlm.nih.gov/31750751Test -
8
المؤلفون: A. Beeks, K.M. Aguilar, Emilie Scherrer, Clemens Krepler, Charles Lance Cowey, M. Boyd
المصدر: Annals of Oncology. 31:S752
مصطلحات موضوعية: Oncology, medicine.medical_specialty, business.industry, Internal medicine, Medicine, Hematology, Pembrolizumab, business, Advanced melanoma
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::375975bb11cf4f9d68096bc15a14b760Test
https://doi.org/10.1016/j.annonc.2020.08.1239Test